Log In
Print this Print this

GSK2190915 (formerly AM803)

Also known as: 2190915

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionNext-generation 5-lipoxygenase activating protein (FLAP) inhibitor
Molecular Target 5-lipoxygenase activating protein (FLAP) (ALOX5AP)
Mechanism of Action5-lipoxygenase activating protein (FLAP) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat mild asthma
Regulatory Designation
PartnerGlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today